NASDAQ: BLTEBelite Bio Inc Stock Ownership - Who owns Belite Bio?
Insider buying vs selling
Have Belite Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Hendrik Peter Scholl | Med | 2026-10-01 | 50 | $166.44 | $8.32kSell |
| Hendrik Peter Scholl | Med | 2026-10-01 | 24 | $164.64 | $3.95kSell |
| Hendrik Peter Scholl | Med | 2026-10-01 | 200 | $163.63 | $32.73kSell |
| Hendrik Peter Scholl | Med | 2026-10-01 | 2 | $170.02 | $340.04Sell |
| Hendrik Peter Scholl | Med | 2026-10-01 | 14 | $169.36 | $2.37kSell |
| Hendrik Peter Scholl | Med | 2026-10-01 | 12 | $168.21 | $2.02kSell |
| Hendrik Peter Scholl | Med | 2026-10-01 | 78 | $167.59 | $13.07kSell |
| Hendrik Peter Scholl | Med | 2026-10-01 | 120 | $165.49 | $19.86kSell |
| Wanshan Chen | Director | 2026-09-24 | 13,796 | $0.44 | $6.06kBuy |
| Haoyuan Chuang | CFO | 2026-09-08 | 4,475 | $196.47 | $879.20kSell |
BLTE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BLTE insiders and whales buy or sell their stock.
BLTE Shareholders
What type of owners hold Belite Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Haoyuan Chuang | 0.53% | 210,264 | $35.74M | Insider |
| Yuhsin Lin | 0.48% | 187,949 | $31.94M | Insider |
| Wanshan Chen | 0.09% | 37,259 | $6.33M | Insider |
| Hendrik Peter Scholl | 0.07% | 29,500 | $5.01M | Insider |
| Darwin | 0.01% | 3,077 | $522.97k | Institution |
| Darwin Global Management Ltd | 0.01% | 3,077 | $522.97k | Institution |
| Parbio | 0.00% | 1,233 | $209.56k | Institution |
| Paradigm Biocapital Advisors LP | 0.00% | 1,232 | $209.39k | Institution |
| Rtw Investments LP | 0.00% | 715 | $121.52k | Institution |
| Rtwinv | 0.00% | 715 | $121.52k | Institution |
BLTE vs Biotech Stocks
Belite Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.